(PubMed) Gorstein JL, Bagriansky J, Pearce EN, Kupka R, Zimmermann MB
Tirzepatide, a dual GIP/GLP-1 agonist, activates a broader pathway and may produce different mood effects in some patientsbetter in some cases, worse in others
Clinically, this often surfaces as cognitive fatigue, difficulty with memory retrieval, and the phenomenon that many women describe as "menofog," a pervasive sense of mental cloudiness that is not simply tiredness but reflects a genuine disruption in how brain cells are producing and managing energy [2]
Find yourself alone in Kenny's room, confronting the depths of your own mind
Marketing language, not a warranty or a clinical claim